Back to Search Start Over

Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration

Authors :
Rory Boyle
Diana L. Townsend
Hannah M. Klinger
Catherine E. Scanlon
Ziwen Yuan
Gillian T. Coughlan
Mabel Seto
Zahra Shirzadi
Wai-Ying Wendy Yau
Roos J. Jutten
Christoph Schneider
Michelle E. Farrell
Bernard J. Hanseeuw
Elizabeth C. Mormino
Hyun-Sik Yang
Kathryn V. Papp
Rebecca E. Amariglio
Heidi I. L. Jacobs
Julie C. Price
Jasmeer P. Chhatwal
Aaron P. Schultz
Michael J. Properzi
Dorene M. Rentz
Keith A. Johnson
Reisa A. Sperling
Timothy J. Hohman
Michael C. Donohue
Rachel F. Buckley
for the Alzheimer’s Disease Neuroimaging Initiative
Source :
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-16 (2024)
Publication Year :
2024
Publisher :
BMC, 2024.

Abstract

Abstract Background Leveraging Alzheimer’s disease (AD) imaging biomarkers and longitudinal cognitive data may allow us to establish evidence of cognitive resilience (CR) to AD pathology in-vivo. Here, we applied latent class mixture modeling, adjusting for sex, baseline age, and neuroimaging biomarkers of amyloid, tau and neurodegeneration, to a sample of cognitively unimpaired older adults to identify longitudinal trajectories of CR. Methods We identified 200 Harvard Aging Brain Study (HABS) participants (mean age = 71.89 years, SD = 9.41 years, 59% women) who were cognitively unimpaired at baseline with 2 or more timepoints of cognitive assessment following a single amyloid-PET, tau-PET and structural MRI. We examined latent class mixture models with longitudinal cognition as the dependent variable and time from baseline, baseline age, sex, neocortical Aβ, entorhinal tau, and adjusted hippocampal volume as independent variables. We then examined group differences in CR-related factors across the identified subgroups from a favored model. Finally, we applied our favored model to a dataset from the Alzheimer’s Disease Neuroimaging Initiative (ADNI; n = 160, mean age = 73.9 years, SD = 7.6 years, 60% women). Results The favored model identified 3 latent subgroups, which we labelled as Normal (71% of HABS sample), Resilient (22.5%) and Declining (6.5%) subgroups. The Resilient subgroup exhibited higher baseline cognitive performance and a stable cognitive slope. They were differentiated from other groups by higher levels of verbal intelligence and past cognitive activity. In ADNI, this model identified a larger Normal subgroup (88.1%), a smaller Resilient subgroup (6.3%) and a Declining group (5.6%) with a lower cognitive baseline. Conclusion These findings demonstrate the value of data-driven approaches to identify longitudinal CR groups in preclinical AD. With such an approach, we identified a CR subgroup who reflected expected characteristics based on previous literature, higher levels of verbal intelligence and past cognitive activity.

Details

Language :
English
ISSN :
17589193
Volume :
16
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Alzheimer’s Research & Therapy
Publication Type :
Academic Journal
Accession number :
edsdoj.533e6b89a4fd4deeb58b8bf4d29de93c
Document Type :
article
Full Text :
https://doi.org/10.1186/s13195-024-01510-y